Dashboard
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 69.46
2
Healthy long term growth as Net Sales has grown by an annual rate of 23.04%
3
Negative results in Dec 24
4
With ROE of 4.97%, it has a Attractive valuation with a 0.52 Price to Book Value
5
Consistent Returns over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.92%
0%
-11.92%
6 Months
25.47%
0%
25.47%
1 Year
30.39%
0%
30.39%
2 Years
77.33%
0%
77.33%
3 Years
114.52%
0%
114.52%
4 Years
26.67%
0%
26.67%
5 Years
-40.09%
0%
-40.09%
PW Medtech Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.04%
EBIT Growth (5y)
42.60%
EBIT to Interest (avg)
69.46
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.13
Tax Ratio
16.20%
Dividend Payout Ratio
92.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.88%
ROE (avg)
8.97%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.52
EV to EBIT
2.89
EV to EBITDA
1.54
EV to Capital Employed
0.17
EV to Sales
0.50
PEG Ratio
NA
Dividend Yield
1.42%
ROCE (Latest)
5.96%
ROE (Latest)
4.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
746.00
624.30
19.49%
Operating Profit (PBDIT) excl Other Income
268.40
165.20
62.47%
Interest
0.20
0.50
-60.00%
Exceptional Items
-0.10
-0.30
66.67%
Consolidate Net Profit
226.60
149.90
51.17%
Operating Profit Margin (Excl OI)
214.30%
118.30%
9.60%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 19.49% vs 90.86% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 51.17% vs -83.17% in Dec 2022
About PW Medtech Group Ltd. 
PW Medtech Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






